Cronos Group Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Cronos Group Inc in the third quarter 2026?
Cronos Group Inc achieved a return on average equity (ROE) of 5.87 % in its third quarter 2026, which is below Cronos Group Inc 's average return on equity, which stands at 41.84%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Legal Cannabis industry 2 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 2086 to 2298.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	3.89 %	-1.13 %	-3.69 %	-1.54 %	-
Y / Y Net Income Change	-51.26 %	-	103.43 %	-	286.69 %
Net Income (TTM) in Millions	65	79	5	-3	42
Return On Equity (TTM)	5.87 %	7.25 %	0.46 %	-0.26 %	3.74 %
CRON's Total Ranking	# 2298	# 2086	# 1736	# 1760	#
Equity (TTM) in Millions	1,125	1,117	1,074	1,094	1,083
Seq. Equity Change	0.64 %	4.08 %	-1.85 %	1.05 %	-4.22 %
Seq. Net Income Change	-61.29 %	126.99 %	-	-	-

Back to CRON Management Effectiveness >> CRON's 5 Years Annual ROE >> Compare CRON ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 3
Sector	# 53
Overall	# 2298

Return On Equity Statistics
High	Average	Low
689.44 %	41.84 %	-27.62 %
(Sep 30 2019)		(Dec 31 2021)

CRON Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	1,094	1,111	1,096	1,141	1,334
Y / Y Equity Change	-1.54 %	1.36 %	-3.93 %	-14.49 %	-21.89 %
Net Income in Millions	-3	40	-75	-169	-397
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-0.27 %	3.6 %	-6.8 %	-14.79 %	-29.77 %

Back to CRON Management Effectiveness >> CRON's 5 Years Annual ROE >> Compare CRON ROE to its Competitors

More Return On Equity Ratios
Legal Cannabis Industry Roe Trends and Statistics
Consumer Non Cyclical Sector Return On Equity Statistics
CRON's' Return on Equity at Yahoo Finance
CRON's Roe Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CRON's Competitors
Subscribers only: Roe for Cronos Group Inc 's Suppliers
Subscribers only: Return On Equity for CRON's Customers

Companies with similar Return On Equity at Sep 30 2026, within Consumer Non Cyclical Sector	ROE
Kenvue Inc	16.06 %
Mondel z International Inc	15.56 %
Sanfilippo John B and Son Inc	15.04 %
Lamb Weston Holdings Inc	14.16 %
Smithfield Foods Inc	13.12 %
Ennis Inc	12.61 %
Archer daniels midland Co	10.71 %
Seaboard Corporation	10.31 %
Est e Lauder Companies Inc	9.37 %
Pilgrim s Pride Corporation	8.49 %
Molson Coors Beverage Company	8.23 %
Millerknoll Inc	7.62 %
Village Farms International Inc	7.27 %
Bunge Global Sa	6.63 %
Educational Development Corporation	4.18 %
Fresh Del Monte Produce Inc	4.10 %
Hni Corporation	2.91 %
Cal maine Foods Inc	2.27 %
Brightview Holdings Inc	1.52 %

Date modified: 2026-11-06T13:01:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.